Evaluation of Neisseria gonorrhoeae Isolates Susceptibility to Antibiotics in Zhejiang Province Since 2007

References

• Rowley J, Vander Hoorn S, Korenromp E, et al. Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019;97(8):548–562p. doi:10.2471/blt.18.228486
   PubMed Web of Science ®Google Scholar
• Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304. doi:10.1371/journal.pone.0143304
   PubMed Web of Science ®Google Scholar
• Jenness SM, Le Guillou A, Lyles C, et al. The role of HIV Partner services in the modern biomedical HIV prevention era: a network modeling study. Sex Transm Dis. 2022;49:801–807. doi:10.1097/olq.0000000000001711
   PubMedGoogle Scholar
• de Araujo-Souza PS, El-Zein M, Bolpetti ADN, et al. Association between human leukocyte antigen polymorphism and human papillomavirus infection in Brazilian women. Sex Transm Dis. 2022;50:50–58. doi:10.1097/olq.0000000000001718
   PubMed Web of Science ®Google Scholar
• Llata E, Braxton J, Asbel L, et al. Presumptive and follow up treatment associated with gonorrhea and chlamydia testing episodes in STD clinics: impact of changing treatment guidelines for gonorrhea, STD surveillance network, 2015–2018. Sex Transm Dis. 2022;50:5–10. doi:10.1097/olq.0000000000001714
   PubMed Web of Science ®Google Scholar
• Unemo M. Current and future antimicrobial treatment of gonorrhoea - the rapidly evolving Neisseria gonorrhoeae continues to challenge. BMC Infect Dis. 2015;15:364. doi:10.1186/s12879-015-1029-2
   PubMed Web of Science ®Google Scholar
• Unemo M, Shafer WM. Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Ann N Y Acad Sci. 2011;1230:E19–28. doi:10.1111/j.1749-6632.2011.06215.x
   PubMed Web of Science ®Google Scholar
• Morse SA, Johnson SR, Biddle JW, Roberts MC. High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother. 1986;30(5):664–670. doi:10.1128/aac.30.5.664
   PubMed Web of Science ®Google Scholar
• Update to CDC’s sexually transmitted diseases treatment guidelines. 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR Morb Mortal Wkly Rep. 2007;56(14):332–336.
   PubMedGoogle Scholar
• Balduck M, Laumen JGE, Abdellati S, et al. Tolerance to ceftriaxone in Neisseria gonorrhoeae: rapid induction in who p reference strain and detection in clinical isolates. Antibiotics. 2022;11(11). doi:10.3390/antibiotics11111480
   Google Scholar
• Verroken A, Hajji C, Bressant F, Couvreur J, Anantharajah A, Rodriguez-Villalobos H. Performance evaluation of the FAST™ System and the FAST-PBC Prep™ cartridges for speeded-up positive blood culture testing. Front Microbiol. 2022;13:982650. doi:10.3389/fmicb.2022.982650
   PubMed Web of Science ®Google Scholar
• Unemo M, Golparian D, Sánchez-Busó L, et al. The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. J Antimicrob Chemother. 2016;71(11):3096–3108. doi:10.1093/jac/dkw288
   PubMed Web of Science ®Google Scholar
• Van Gerwen OT, Muzny CA, Marrazzo JM. Sexually transmitted infections and female reproductive health. Nat Microbiol. 2022;7(8):1116–1126. doi:10.1038/s41564-022-01177-x
   PubMed Web of Science ®Google Scholar
• Baarda BI, Martinez FG, Sikora AE. Proteomics, bioinformatics and structure-function antigen mining for gonorrhea vaccines. Front Immunol. 2018;9:2793. doi:10.3389/fimmu.2018.02793
   PubMed Web of Science ®Google Scholar
• Quillin SJ, Seifert HS. Neisseria gonorrhoeae host adaptation and pathogenesis. Rev Nat Rev Microbiol. 2018;16(4):226–240. doi:10.1038/nrmicro.2017.169
   PubMed Web of Science ®Google Scholar
• Unemo M, Seifert HS, Hook EW, Hawkes S, Ndowa F, Dillon JR. Gonorrhoea. Nat Rev Dis Primers. 2019;5(1):79. doi:10.1038/s41572-019-0128-6
   PubMed Web of Science ®Google Scholar
• Unemo M. The 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults recommends dual antimicrobial therapy. Euro Surveillance. 2012;17(47). doi:10.2807/ese.17.47.20323-en
   Google Scholar
• Merrick R, Cole M, Pitt R, et al. Antimicrobial-resistant gonorrhoea: the national public health response, England, 2013 to 2020. Euro Surveill. 2022;27(40). doi:10.2807/1560-7917.Es.2022.27.40.2200057
   PubMedGoogle Scholar
• Wang F, Liu JW, Li YZ, et al. Surveillance and molecular epidemiology of Neisseria gonorrhoeae isolates in Shenzhen, China, 2010–2017. J Glob Antimicrob Resist. 2020;23:269–274. doi:10.1016/j.jgar.2020.08.013
   PubMed Web of Science ®Google Scholar
• Nokchan N, Wongsurawat T, Jenjaroenpun P, Nitayanon P, Tribuddharat C. Whole-genome sequence analysis of high-level penicillin-resistant strains and antimicrobial susceptibility of Neisseria gonorrhoeae clinical isolates from Thailand. PLoS One. 2022;17(7):e0271657. doi:10.1371/journal.pone.0271657
   PubMed Web of Science ®Google Scholar
• Shariati A, Arshadi M, Khosrojerdi MA, et al. The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic. Front Public Health. 2022;10:1025633. doi:10.3389/fpubh.2022.1025633
   PubMed Web of Science ®Google Scholar
• Kueakulpattana N, Wannigama DL, Luk-In S, et al. Multidrug-resistant Neisseria gonorrhoeae infection in heterosexual men with reduced susceptibility to ceftriaxone, first report in Thailand. Sci Rep. 2021;11(1):21659. doi:10.1038/s41598-021-00675-y
   PubMed Web of Science ®Google Scholar
• Chen SC, Han Y, Yuan LF, Zhu XY, Yin YP. Identification of internationally disseminated ceftriaxone-resistant Neisseria gonorrhoeae strain FC428, China. Emerg Infect Dis. 2019;25(7):1427–1429. doi:10.3201/eid2507.190172
   PubMed Web of Science ®Google Scholar
• Chen SC, Yin YP, Dai XQ, Unemo M, Chen XS. First nationwide study regarding ceftriaxone resistance and molecular epidemiology of Neisseria gonorrhoeae in China. J Antimicrob Chemother. 2016;71(1):92–99. doi:10.1093/jac/dkv321
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000–2010. MMWR Morb Mortal Wkly Rep. 2011;60(26):873–877.
   PubMedGoogle Scholar
• Tanaka M, Furuya R, Kobayashi I, Kanesaka I, Ohno A, Katsuse AK. Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996–2016. J Glob Antimicrob Resist. 2019;17:3–7. doi:10.1016/j.jgar.2018.11.011
   PubMed Web of Science ®Google Scholar
• Yin YP, Han Y, Dai XQ, et al. Susceptibility of Neisseria gonorrhoeae to azithromycin and ceftriaxone in China: a retrospective study of national surveillance data from 2013 to 2016. PLoS Med. 2018;15(2):e1002499. doi:10.1371/journal.pmed.1002499
   PubMed Web of Science ®Google Scholar
• Golparian D, Kittiyaowamarn R, Paopang P, et al. Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018. J Antimicrob Chemother. 2022;77(8):2171–2182. doi:10.1093/jac/dkac158
   PubMed Web of Science ®Google Scholar
• Lin EY, Adamson PC, Ha SM, Klausner JD. Reliability of genetic alterations in predicting ceftriaxone resistance in Neisseria gonorrhoeae globally. Microbiol Spectr. 2022;10(2):e0206521. doi:10.1128/spectrum.02065-21
   PubMed Web of Science ®Google Scholar
• Goytia M, Wadsworth CB. Canary in the coal mine: how resistance surveillance in commensals could help curb the spread of amr in pathogenic Neisseria. mBio. 2022;13(5):e0199122. doi:10.1128/mbio.01991-22
   PubMed Web of Science ®Google Scholar
• Vanbaelen T, Van Dijck C, Laumen J, et al. Global epidemiology of antimicrobial resistance in commensal Neisseria species: a systematic review. Int J Med Microbiol. 2022;312(3):151551. doi:10.1016/j.ijmm.2022.151551
   PubMed Web of Science ®Google Scholar
• Lin X, Qin X, Wu X, et al. Markedly increasing antibiotic resistance and dual treatment of Neisseria gonorrhoeae isolates in Guangdong, China, from 2013 to 2020. Antimicrob Agents Chemother. 2022;66(4):e0229421. doi:10.1128/aac.02294-21
   PubMed Web of Science ®Google Scholar
• Somsri M, Oransathid W, Vesely B, et al. Antimicrobial susceptibility of Neisseria gonorrhoeae in adult patients seeking care at military hospitals in Thailand From 2014 to 2020. Mil Med. 2022. doi:10.1093/milmed/usab549
   PubMed Web of Science ®Google Scholar